Objective." The purposes of this study were to compare the efficacy of amoxicillin and cephradine for the treatment of sporadic acute puerperal mastitis (SAPM) and to evaluate the microbiology and clinical parameters of this infection.
poradic acute puerperal mastitis (SAPM) has been a recognized complication of breast-feeding since the process began. In 1953, Gibberd categorized puerperal infections of the breast as epidemic and nonepidemic (sporadic). Epidemic mastitis is defined as acute adenitis and cellulitis primarily involving the lactiferous apparatus of the breast and often including nonadjacent lobes. It is usually seen in hospital outbreaks with transmission among mothers, babies, and hospital personnel. Most cases are caused by virulent strains ofStaphylococcus aureus. '2 Nonepidemic mastitis is defined as acute puerperal cellulitis with extension to the periglandular connective tissue. This connective-tissue infection results in a V-shaped area of involvement among the lobes.
S. aureus, staphylococcal species (coagulase negative), group B streptococci, enterobacteriaceae, and anaerobic bacteria have been isolated from the milk of mothers with mastitis. 3'4 There are also data that potentially pathogenic bacteria may be isolated from the milk of nursing mothers who are not clinically infected, Actually, mastitis is a clinical and pathologic term that describes any inflammatory condition of the breast. The most frequent of these conditions is puerperal mastitis, an infection of the breast producing localized tenderness, erythema, and heat together with flu-like symptoms. Modern studies have reported the incidence of SAPM to be 2.5-2.9% of lactating mothers. 5 (Table 3) .
There was recurrence within 30 days of treatment in the amoxicillin group. This patient's admission culture grew S. aureus and her culture at the time of the recurrence grew the same organism. There were 2 recurrences within 30 days in the cephradine group, with both culturing coagulasenegative staphylococcal species at admission to the study. The cultures at the time of recurrence on both of these patients were negative (Table 3) .
One patient in each group had bilateral breast involvement, including the patient with the unilateral abscess. There were no adverse side effects to the antibiotics administered. The women were questioned about compliance with dosing at the return visit, and all indicated that they had taken their medication as prescribed.
DISCUSSION
SAPM is an infection of the breast that complicates breast-feeding in 2.5-2.9% of women, according to modern studies. 5 In our study of lactating mothers, S. aureus was recovered from the milk of 3 amoxicillin-treated women and 4 cephradine-treated women, for a total isolation rate of 28%. Staphylococcal species (coagulase negative) were isolated from the milk of 4 amoxicillin-treated and 4 cephradine-treated mothers, for a total isolation rate of 32%. These isolation rates are consistent with those referenced above. Since 60% of the mothers had staphylococci cultured from their milk, it seems prudent to treat women with SAPM with an antibiotic that is effective against these bacteria, if these bacteria truly infect the breast parenchyma.
All of the staphylococcal isolates were resistant to penicillin and sensitive to cephalosporins. Both treatment failures occurred in the amoxicillin group, and both patients' cultures grew S. aureus upon admission to the study and at the time of their assessments as treatment failures. One of these women developed a breast abscess; the other responded when her antibiotic was changed to cephradine. The culture of the amoxicillin-treated patient with a recurrence also grew staphylococcal species (coagulase negative) and she responded to treatment with cephradine.
Among the amoxicillin-treated group, whose culture grew S. aureus and 4 whose cultures grew staphylococcal species responded to treatment in spite of the fact that the isolates were resistant in vitro. This finding may emphasize the importance of emptying the breast and using warm, moist compresses in the treatment of SAPM.
We recognize that the number of patients in this study is small. In a post hoc analysis, if we assume a 15% failure rate for amoxicillin and a 1% failure rate for cephradine, with an ot of 0.05 and desired power of 0.8, 72 patients would be required for each arm of the study using a continuity correction for small numbers. Based on our recruitment of nursing mothers, a delivery population of 3,264 women would be required. We will continue to recruit more patients to achieve these numbers and will report those data.
There was no statistically significant difference
